glp 1 heart failure GLP-1 Receptor Agonists in Management Vascular and metabolic effects of

These include short-acting agents (e.g., exenatide BID), long-acting formulations (e.g., liraglutide, semaglutide, dulaglutide), dual agonists such as tirzepatide (GIP/GLP-1 RA), and novel oral agents like orforglipron and danuglipron

[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Arakawa M., Mita T., Azuma K., et al

But some telehealth companies are marketing GLP-1s as an easy way to lose weight sometimes with the help of paid celebrity endorsements without emphasizing the importance of healthy eating and exercise, she said

Progressive resistance training 2 to 3 times per week

At Josie, your provider helps you choose what fits best

K., Twells, L